We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DEA Classifies Tramadol as Schedule IV, Creating New Requirements for Drugmakers
DEA Classifies Tramadol as Schedule IV, Creating New Requirements for Drugmakers
Tramadol manufacturers have approximately 45 days to implement new labeling and security procedures now that the Drug Enforcement Administration has determined the opioid analgesic is a Schedule IV controlled substance.